Cargando…
Application of a High Throughput Method of Biomarker Discovery to Improvement of the EarlyCDT(®)-Lung Test
BACKGROUND: The National Lung Screening Trial showed that CT screening for lung cancer led to a 20% reduction in mortality. However, CT screening has a number of disadvantages including low specificity. A validated autoantibody assay is available commercially (EarlyCDT®-Lung) to aid in the early det...
Autores principales: | Macdonald, Isabel K., Murray, Andrea, Healey, Graham F., Parsy-Kowalska, Celine B., Allen, Jared, McElveen, Jane, Robertson, Chris, Sewell, Herbert F., Chapman, Caroline J., Robertson, John F. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521770/ https://www.ncbi.nlm.nih.gov/pubmed/23272083 http://dx.doi.org/10.1371/journal.pone.0051002 |
Ejemplares similares
-
EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays
por: Chapman, Caroline J., et al.
Publicado: (2012) -
Development and Validation of a High Throughput System for Discovery of Antigens for Autoantibody Detection
por: Macdonald, Isabel K., et al.
Publicado: (2012) -
Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma
por: Welberry, Christopher, et al.
Publicado: (2020) -
Serum Autoantibody Measurement for the Detection of Hepatocellular Carcinoma
por: Middleton, Catrin H., et al.
Publicado: (2014) -
Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial
por: Sullivan, F. M., et al.
Publicado: (2017)